Cinven to become lead investor in Vitamin Well

Cinven, an international private equity firm focused on building world-class global and European companies, has reached an agreement to become the lead investor in Vitamin Well, a Swedish provider of protein bars and sport and health beverages.

Going forward, Bridgepoint, the current majority investor, will retain a significant minority stake in Vitamin Well. The transaction is subject to regulatory approvals and other customary closing conditions.

Vitamin Well, with its headquarters in Stockholm, was established 2008 and is a fast-growing functional food and beverage business, offering premium products for health-conscious and active consumers. Vitamin Well has approximately 500 employees and a broad product portfolio across several brands, including Vitamin Well, NOCCO and Barebells, which are sold internationally across more than 40 markets.

Cinven was advised on the transaction by Mannheimer Swartling, who partnered with the global law firm Freshfields Bruckhaus Deringer.